Lupin receives tentative approval from USFDA for DETAF tablets
DETAF would be a welcome new addition in the management of HIV infections and will be available for supplies to low- and middle-income countries
DETAF would be a welcome new addition in the management of HIV infections and will be available for supplies to low- and middle-income countries
The Survey highlighted that Indian pharmaceutical exports achieved a healthy growth of 24 per cent in FY21 and expressed hope that India’s domestic pharmaceutical market is estimated to grow to US $65 billion by 2024 from estimated US $41 billion in 2021
Diagnostic imaging will become an increasingly vital process in healthcare
It will help upgrade the infrastructure and technologies of the country's biopharmaceuticals and in-vitro diagnostic industry
Asthma patients are more likely to have an asthma attack during winter
Products offered on a not-for-profit basis to the 45 lower-income countries now include the full portfolio for which Pfizer has global rights.
OrbiMed's exercise of warrant conversion will further strengthen the company's net cash position to over Rs.650 crores.
There is a great opportunity for utilizing traditional medical practices like Ayurveda in Value Based Healthcare
Connectivity and harmonisation were both key driving factors behind our decision to choose the CARA Life Sciences Platform to consolidate our processes
New facility is based at Lonza’s Bend, Oregon (US) site, a Center of Excellence for bioavailability enhancement
Subscribe To Our Newsletter & Stay Updated